Additions:
Based upon the gold standard Affymetrix ""GeneChip""? technology, the DSA? research tools provide multiple independent measurements for each transcript and content is both reliable and reproducible.
Deletions:
Additions:
David Sumner, Chief Executive of Medicsight, one of the industry leaders in the development of computer-aided detection (CAD) and image analysis software, said: "We welcome the results of this landmark study, confirming our belief that CT colonography is a genuine and robust option in the armamentarium that physicians have at their disposal when screening for colorectal cancer. This is likely to lead to a material increase in the use of CT colonography for screening populations who are most at risk of developing this devastating condition. Medicsight's ""ColonCAD""? software, which can be used with multi-detector CT imaging equipment, helps radiologists to interpret the CT scans and identify early-stage lesions."
Deletions:
Additions:
* 21,968 (42%) are present in the human ""RefSeq"" database
* 26,676 (51%) of transcripts are not present in the human ""RefSeq"" database
* 26,676 (51%) of transcripts are not present in the human ""RefSeq"" database
Deletions:
* 26,676 (51%) of transcripts are not present in the human RefSeq database
Additions:
Merck ""KGaA"" announced that it has submitted an application to the European Medicines Agency (EMEA) to broaden the use of the targeted cancer therapy, Erbitux (cetuximab), to include first-line therapy for the treatment of metastatic colorectal cancer (mCRC).
